Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression

Oncogene

Volumn 33, Issue 27, 2014, Pages 3583-3593

  Kim, E S ^a   Cha, Y ^a   Ham, M ^a   Jung, J ^a   Kim, S G ^b   Hwang, S ^c   Kleemann, R ^d   Moon, A ^a  

^a Duksung Women's University   (South Korea)

^b Seoul National University   (South Korea)

^c Hanyang University   (South Korea)

^d TNO   (Netherlands)

Author keywords

breast cell; C reactive protein; invasion; MMP 9; S1P

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; C REACTIVE PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; FINGOLIMOD; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE KINASE; REACTIVE OXYGEN METABOLITE; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; BREAST CELL; CANCER GROWTH; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY BREAST CANCER; MOUSE; NONHUMAN; ONCOGENE C FOS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TUMOR INVASION; UPREGULATION; XENOGRAFT;

MUS;

ANIMALS; BREAST NEOPLASMS; C-REACTIVE PROTEIN; CALCIUM; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; DISEASE PROGRESSION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; INFLAMMATION; LYSOPHOSPHOLIPIDS; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-FOS; REACTIVE OXYGEN SPECIES; SPHINGOSINE; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84903886518     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.319     Document Type: Article

References (92)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin 2007; 57: 43-66.
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
4. Hojilla CV, Wood GA, Khokha R. Inflammation and breast cancer: metalloprotei-nases as common effectors of inflammation and extracellular matrix breakdown in breast cancer. Breast Cancer Res 2008; 10: 205.
5. Cole SW. Chronic inflammation and breast cancer recurrence. J Clin Oncol 2009; 27: 3418-3419.
6. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001; 38: 189-197.
7. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004; 291: 585-590.
8. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009; 27: 3437-3444.
9. Allin KH, Nordestgaard BG, Flyger H, Bojesen SE. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res 2011; 13: R55.
10. Ravishankaran P, Karunanithi R. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J Surg Oncol 2011; 9: 18.
11. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52-67.
12. Lelongt B, Trugnan G, Murphy G, Ronco PM. Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 1997; 136: 1363-1373.
13. Sarén P, Welgus HG, PT. Kovanen. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4159-4165.
14. Przybylowska K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat 2006; 95: 65-72.
15. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodríguez JA et al. CRP induces matrix metalloproteinase-1 and-10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 2006; 47: 1369-1378.
16. Nabata A, Kuroki M, Ueba H, Hashimoto S, Umemoto T, Wada H et al. C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis 2008; 196: 129-135.
17. Doronzo G, Russo I, Mattiello L, Trovati M, Anfossi G. CRP increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. J Lab Clin Med 2005; 146: 287-298.
18. Van Brocklyn JR, Lee MJ, Menzeleev R, Olivera A, Edsall L, Cuvillier O et al. Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 1998; 142: 229-240.
19. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J 2001; 15: 1212-1214.
20. Hammad SM, Crellin HG, Wu BX, Melton J, Anelli V, Obeid LM. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. Prostaglandins Other Lipid Mediat 2008; 85: 107-114.
21. Smicun Y, Reierstad S, Wang FQ, Lee C, Fishman DA. S1P regulation of ovarian carcinoma invasiveness. Gynecol Oncol 2006; 103: 952-959.
22. Shida D, Fang X, Kordula T, Takabe K, Lépine S, Alvarez SE et al. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 2008; 68: 6569-6577.
23. Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer Res 2012; 72: 726-735.
24. Kim ES, Kim JS, Kim SG, Hwang S, Lee CH, Moon A. Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Gaq coupling. J Cell Sci 2011; 124: 2220-2230.
25. Radeke HH, von Wenckstern H, Stoidtner K, Sauer B, Hammer S, Kleuser B. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J Immunol 2005; 174: 2778-2786.
26. Paugh SW, Payne SG, Barbour SE, Milstien S, Spiegel S. The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett 2003; 554: 189-193.
27. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63: 5962-5969.
28. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 2003; 101: 545-551.
29. Young DP, Kushner I, Samols D. Binding of C/EBPbeta to the C-reactive protein (CRP) promoter in Hep3B cells is associated with transcription of CRP mRNA. J Immunol 2008; 181: 2420-2427.
30. Hurst HC. Transcription factors. 1: bZIP proteins. Protein Profile 1994; 1: 123-168.
31. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998; 273: 28545-28548.
32. Windh RT, Lee MJ, Hla T, An S, Barr AJ, Manning DR. Differential coupling of the sphingosine-1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq and G12 families of heterotrimeric G proteins. J Biol Chem 1999; 274: 27351-27358.
33. Jongsma M, van Unen J, van Loenen PB, Michel MC, Peters SL, Alewijnse AE. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). Br J Pharmacol 2009; 156: 1305-1311.
34. Koid Y, Hasegawa T, Takahashi A, Endo A, Mochizuki N, Nakagawa M et al. Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. J Med Chem 2002; 45: 4629-4638.
35. Okajima F, Tomura H, Sho K, Kimura T, Sato K, Im DS et al. Sphingosine 1-phosphate stimulates hydrogen peroxide generation through activation of phospholipase C-Ca2 system in FRTL-5 thyroid cells: possible involvement of guanosine triphosphate-binding proteins in the lipid signaling. Endocrinology 1997; 138: 220-229.
36. Sato K, Kon J, Tomura H, Osada M, Murata N, Kuwabara A et al. Activation of phospholipase C-Ca2 system by sphingosine 1-phosphate in CHO cells trans-fected with Edg-3, a putative lipid receptor. FEBS Lett 1999; 443: 25-30.
37. Wilsher NE, Court WJ, Ruddle R, Newbatt YM, Aherne W, Sheldrake PW et al. The phosphoinositide-specific phospholipase C inhibitor U73122 (1-(6-((17beta-3-methoxyestra-1, 3, 5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2, 5-dione) spontaneously forms conjugates with common components of cell culture medium. Drug Metab Dispos 2007; 35: 1017-1022.
38. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ. Activation of mitogen-activated protein kinase by H2O2. J Biol Chem 1996; 271: 4138-4142.
39. Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2007; 27: e302-e307.
40. Chang JW, Kim CS, Kim SB, Park SK, Park JS, Lee SK. C-reactive protein induces NF-kappaB activation through intracellular calcium and ROS in human mesangial cells. Nephron Exp Nephrol 2005; 101: e165-e172.
41. Masamune A, Watanabe T, Kikuta K, Satoh K, Shimosegawa T. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2008; 294: G99-G108.
42. Price MO, Atkinson SJ, Knaus UG, Dinauer MC. Rac activation induces NADPH oxidase activity in transgenic COSphox cells, and the level of superoxide production is exchange factor-dependent. J Biol Chem 2002; 277: 19220-19228.
43. Hu J, Roy SK, Shapiro PS, Rodig SR, Reddy SP, Platanias LC et al. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma. J Biol Chem 2001; 276: 287-297.
44. Salmenperä P, Hämäläinen S, Hukkanen M, Kankuri E. Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells. Am J Physiol Cell Physiol 2003; 284: C1133-C1139.
45. Lewis CE, Hughes R. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 2007; 9: 209.
46. Goldberg JE, Schwertfeger KL. Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics. Curr Drug Targets 2010; 11: 1133-1146.
47. Depraetere S, Willems J, Joniau M. Stimulation of CRP secretion in HepG2 cells: cooperative effect of dexamethasone and interleukin 6. Agents Actions 1991; 34: 369-375.
48. Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L et al. C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol 2006; 146: 533-539.
49. Venugopal SK, Devaraj S, Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol 2005; 166: 1265-1271.
50. Lei KJ, Liu T, Zon G, Soravia E, Liu TY, Goldman ND. Genomic DNA sequence for human C-reactive protein. J Biol Chem 1985; 260: 13377-13383.
51. Woo P, Korenberg JR, Whitehead AS. Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem 1985; 260: 13384-13388.
52. Tron K, Manolov DE, Röcker C, Kächele M, Torzewski J, Nienhaus GU. C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line. Eur J Immunol 2008; 38: 1414-1422.
53. Lu J, Marjon KD, Marnell LL, Wang R, Mold C, Du Clos TW et al. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc Natl Acad Sci USA 2011; 108: 4974-4979.
54. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989; 8: 3773-3779.
55. Moshage HJ, Roelofs HM, van Pelt JF, Hazenberg BP, van Leeuwen MA et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988; 155: 112-117.
56. Nishikawa T, Hagihara K, Serada S, Isobe T, Matsumura A, Song J et al. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol 2008; 180: 3492-3501.
57. Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009; 6: 118.
58. Du Clos TW. Function of C-reactive protein. Ann Med 2000; 32: 274-278.
59. Swanson SJ, McPeek MM, Mortensen RF. Characteristics of the binding of human C-reactive protein (CRP) to laminin. J Cell Biochem 1989; 40: 121-132.
60. Suresh MV, Singh SK, Agrawal A. Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications. J Biol Chem 2004; 279: 52552-52557.
61. Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A et al. Inter-leukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 2007; 282: 27229-27238.
62. Kaur G, Rao LV, Agrawal A, Pendurthi UR. Effect of wine phenolics on cytokine-induced C-reactive protein expression. J Thromb Haemost 2007; 5: 1309-1317.
63. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1005-L1028.
64. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
65. Li J, Shao ZH, Xie JT, Wang CZ, Ramachandran S, Yin JJ et al. The effects of ginsenoside Rb1 on JNK in oxidative injury in cardiomyocytes. Arch Pharm Res 2012; 35: 1259-1267.
66. Catarzi S, Giannoni E, Favilli F, Meacci E, Iantomasi T, Vincenzini MT. Sphingosine 1-phosphate stimulation of NADPH oxidase activity: relationship with platelet-derived growth factor receptor and c-Src kinase. Biochim Biophys Acta 2007; 1770: 872-883.
67. Tanimoto T, Lungu AO, Berk BC. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ Res 2004; 94: 1050-1058.
68. Dai DF, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF et al. Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardio-myopathy. J Am Coll Cardiol 2011; 58: 73-82.
69. Tobar N, Guerrero J, Smith PC, Martínez J. NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. Br J Cancer 2010; 103: 1040-1047.
70. Devaraj S, Dasu MR, Singh U, Rao LV, Jialal I. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis 2009; 203: 67-74.
71. Wu ZS, Wu Q, Yang JH, Wang HQ, Ding XD, Yang F et al. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. Int J Cancer 2008; 122: 2050-2056.
72. Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008; 118: 3012-3024.
73. Kim MS, Lee EJ, Kim HR, Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 2003; 63: 454-5461.
74. Shin I, Kim S, Song H, Kim HR, Moon A. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Che 2005; 280: 4675-14683.
75. Kim ES, Jeong JB, Kim S, Lee KM, Ko E, Noh DY et al. The G(12) family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Res Treat 2010; 124: 49-61.
76. Yong HY, Hwang JS, Son H, Park HI, Oh ES, Kim HH et al. Identification of H-Ras-specific motif for the activation of invasive signaling program in human breast epithelial cells. Neoplasia 2011; 13: 98-107.
77. Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S. Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 2002; 281: 115-127.
78. Goetzl EJ, Dolezalova H, Kong Y, Zeng L. Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. Cancer Res 1999; 59: 4732-4737.
79. Long JS, Fujiwara Y, Edwards J, Tannahill CL, Tigyi G, Pyne S et al. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J Biol Chem 2010; 285: 35957-35966.
80. Bodmer B, Siboo R. Isolation of mouse C-reactive protein from liver and serum. J Immunol 1977; 118: 1086-1089.
81. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111: 1805-1812.
82. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE et al. Impaired endo-thelial function in C-reactive protein overexpressing mice. Atherosclerosis 2008; 201: 318-325.
83. Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY et al. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011; 218: 44-52.
84. Azuma H, Takahara S, Ichimaru N, Wang JD, Itoh Y, Otsuki Y et al. Marked prevention of tumor growth and metastasis by a novel immunosuppressive agent, FTY720, in mouse breast cancer models. Cancer Res 2002; 62: 1410-1419.
85. Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio MV et al. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res 2010; 70: 8651-8661.
86. Schneider G, Bryndza E, Abdel-Latif A, Ratajczak J, Maj M, Tarnowski M et al. Bioactive lipids S1P and C1P are pro-metastatic factors in human rhabdomyo-sarcomas cell lines, and their tissue level increases in response to radio/ chemotherapy. Mol Cancer Res 2013; 11: 793-807.
87. Moon A, Kim MS, Kim TG, Kim SH, Kim HE, Chen YQ et al. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: a role for MMP-2 in the H-rasinduced invasive phenotype. Int J Cancer 2000; 85: 176-181.
88. Cha Y, Kang Y, Moon A. HER2 induces expression of leptin in human breast epithelial cells. BMB Rep 2012; 45: 719-723.
89. Han C, Liu J, Liu X, Li M. Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells. Atherosclerosis 2010; 212: 206-212.
90. Song H, Ki SH, Kim SG, Moon A. Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res 2006; 66: 0487-10496.
91. Ma Z, Qin H, Benveniste EN. Transcriptional suppression of matrix metallopro-teinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 2001; 167: 5150-5159.
92. Bonnaud S, Niaudet C, Legoux F, Corre I, Delpon G, Saulquin X et al. Sphingosine-1-phosphate activates that AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. Cancer Res 2010; 70: 9905-9915.